News Articles for Roby Zomer

Board moves May 11, 2026

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Today's board moves wrap includes Graeme Pettit, Natalie Madden, John Simpson, Alexander Neuling, Zaiqian Zhang, Stefan Murphy, Shawn Tilley, Jesper Sentow, Jenny Tan, Andrew Caruso, Terry Holohan, James Scott, Andrew Chapman, Roby Zomer, Gary Hermon, Justin Brown, Melissa Peters, Warrick Clent and more.

WA cannabis companies in shake up

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Argent Biopharma has streamlined its asset acquisition of fellow WA cannabis player AusCann, while another Perth player has been subject to a reverse takeover.

MGC Pharma secures $33m in sales

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Shares in MGC Pharmaceuticals have risen more than 40 per cent after the WA company revealed first orders for its plant-derived medicinal products in the US.

MGC Pharma to acquire Israeli business

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Biopharma company MGC Pharmaceuticals has proposed to buy an Israeli clinical research business for $6 million in shares.

Research a driver for cannabis

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

The strong growth of the medicinal cannabis industry will need to be supported by research for the sector to take the next step.

Board Moves May 15, 2018

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Admedus has appointed Michael Oswell to the newly created role of vice president, development. Based in the US, Mr Oswell has extensive experience in the medical technology industry.

MGC secures cannabis build contract in Malta

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

ASX-listed MGC Pharmaceuticals announced today that is has been awarded a contract to build a medical cannabis production facility in Malta, with a $5 million capital raising set to help fund the project.

MGC in Korean supply deal

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Medical cannabis company MGC Pharmaceuticals has locked in a supply agreement that it expects to net about $20 million in annual revenue.

Board Moves May 12, 2017

Bookmark

Save articles for future reference.

Subscribe to BN Log In

Share to

• Facebook
• X
• LinkedIn

Roby Zomer, founder of MGC Pharmaceuticals, has been appointed chief executive officer. Mr Zomer was its executive director and chief technical officer prior to this appointment.